• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Lumisys to debut low-cost CR reader

Article

X-ray film digitizer firm Lumisys announced that it will begin developing a low-cost computed radiography reader for the medical market. Because a key patent held by CR market leader Fuji expires in 1998, the Sunnyvale, CA-based company believes it can

X-ray film digitizer firm Lumisys announced that it will begin developing a low-cost computed radiography reader for the medical market. Because a key patent held by CR market leader Fuji expires in 1998, the Sunnyvale, CA-based company believes it can enter the CR market without fear of infringing on Fuji's patents.

Although Lumisys would not release many details, project development will begin in the second quarter of 1997 and is expected to take two years. The medical CR reader will employ technology developed for a CR reader that Lumisys has been selling into the nondestructive test market since 1996.

Lumisys revealed the product development plans during a teleconference with industry analysts to discuss its 1997 first-quarter results (end-March). Lumisys posted revenue of $5.8 million, an increase of 14% over the same period in 1996, when Lumisys had sales of $5.1 million.

Now reporting earnings on a fully taxed basis, Lumisys netted normalized income of $788,000 in the first quarter, a 57% gain over normalized earnings from the first quarter of 1996. Earnings per share, however, were slightly below some analysts' expectations, which led to a drop in the company's stock. Lumisys shares closed at $5.88 on April 23, a 52-week low.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.